Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats

Behavioural Brain Research

Volumn 162, Issue 1, 2005, Pages 99-107

  Bertoglio, Leandro José ^a   Anzini, Cláudia ^b   Lino De Oliveira, Cilene ^b   Carobrez, Antônio Pádua ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; Benzodiazepine; Elevated plus maze; Fear; One trial tolerance; Periaqueductal gray

Indexed keywords

LIDOCAINE; MIDAZOLAM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPLORATORY BEHAVIOR; FEAR; MALE; MAZE TEST; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; TRANQUILIZING ACTIVITY;

ANESTHETICS, LOCAL; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; LIDOCAINE; MALE; MAZE LEARNING; MIDAZOLAM; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR;

EID: 19444376043     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.03.010     Document Type: Article

References (43)

1. R. Bandler, and M.T. Shipley Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends Neurosci 17 9 1994 379 389
2. L.J. Bertoglio, and A.P. Carobrez Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety Behav Brain Res 108 2 2000 197 203
3. L.J. Bertoglio, and A.P. Carobrez Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze Pharmacol Biochem Behav 73 4 2002 963 969
4. L.J. Bertoglio, and A.P. Carobrez Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions Behav Brain Res 132 2 2002 135 143
5. L.J. Bertoglio, and A.P. Carobrez Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze Pharmacol Biochem Behav 72 2002 449 455
6. L.J. Bertoglio, and A.P. Carobrez Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze Trial 2 in rats Psychopharmacology 170 2003 335 342
7. L.J. Bertoglio, and A.P. Carobrez Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon on the elevated plus-maze Trial 2 Behav Pharmacol 15 1 2004 45 54
8. A.A. Cameron, I.A. Khan, K.N. Westlund, K.D. Cliffer, and W.D. Willis The efferent projections of the periaqueductal gray in the rat: a phaseolus vulgaris-leucoagglutinin study. I. Ascending projections J Comp Neurol 351 1995 568 584
9. A. Canto-de-Souza, R. Luiz Nunes-de-Souza, and R.J. Rodgers Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience Brain Res 928 1-2 2002 50 59
10. A.P. Carobrez, K.V. Teixeira, and F.G. Graeff Modulation of defensive behavior by periaqueductal gray NMDA/glycine-B receptor Neurosci Biobehav Rev 25 2001 697 709
11. S.E. Cruz-Morales, N.R. Santos, and M.L. Brandão One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat Pharmacol Biochem Behav 72 2002 973 978
12. M.L.C. Dal-Col, L. Orlandi-Pereira, V.P. Rosa, A.V. Calixto, A.P. Carobrez, and M.S. Faria Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1 Pharmacol Biochem Behav 74 2 2003 395 400
13. G.R. Dawson, S.P. Crawford, K.J. Stanhope, S.D. Iversen, and M.D. Tricklebank One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure Psychopharmacology 113 3-4 1994 570 572
14. S.E. File The interplay of learning and anxiety in the elevated plus-maze Behav Brain Res 58 1-2 1993 199 202
15. S.E. File, and H. Zangrossi Jr. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology 110 1-2 1993 240 244
16. S.E. File, P.S. Mabbutt, and P.K. Hitchcott Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze Psychopharmacology 102 1 1990 98 101
17. S.E. File, H. Zangrossi Jr., M. Viana, and F.G. Graeff Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology 111 4 1993 491 494
18. R. Frussa-Filho, and R.A. de Ribeiro One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure Life Sci 71 5 2002 519 525
19. S.E. File, L.E. Gonzalez, and R. Gallant Role of the basolateral nucleus of the amygdala in the formation of a phobia Neuropsychopharmacology 19 5 1998 397 405
20. S.E. File, L.E. Gonzalez, and R. Gallant Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety Neuropsychopharmacology 21 2 1999 312 320
21. L.E. Gonzalez, and S.E. File A five-minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus J Neurosci 17 4 1997 1505 1511
22. F.G. Graeff Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals Braz J Med Biol Res 27 4 1994 11 29
23. A.J. Gray, and N. McNaughton The neuropsychology of anxiety 2nd ed. 2000 Oxford University Press New York p. 72-82
24. A. Holmes, and R.J. Rodgers Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state? Pharmacol Biochem Behav 60 2 1998 473 488
25. A. Holmes, and R.J. Rodgers Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze Neurosci Biobehav Rev 23 7 1999 971 980
26. C. Lino-de-Oliveira, T.C. De Lima, and A.P. Carobrez Dorsal periaqueductal gray matter inhibits passive coping strategy elicited by forced swimming stress in rats Neurosci Lett 335 2 2002 87 90
27. R.G. Lister The use of a plus-maze to measure anxiety in the mouse Psychopharmacology 92 2 1987 180 185
28. T.A. Lovick Panic disorder - a malfunction of multiple transmitter control systems within the midbrain periaqueductal gray matter Neuroscientist 6 2000 48 59
29. J.G. Malpelli Reversible inactivation of subcortical sites by drug injection J Neurosci Methods 86 1999 119 128
30. N. McNaughton, and P.J. Corr A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance Neurosci Biobehav Rev 28 3 2004 285 305
31. R. Misslin The defense system of fear: behavior and neurocircuitry Neurophysiol Clin 33 2 2003 55 66
32. B.S. Nashold Jr., W.P. Wilson, and D.G. Slaughter Sensations evoked by stimulation in the midbrain of man J Neurosurg 30 1 1969 14 24
33. A. Nelovkov, M.A. Philips, S. Koks, and E. Vasar Rats with low exploratory activity in the elevated plus-maze have the increased expression of limbic system-associated membrane protein gene in the periaqueductal grey Neurosci Lett 352 3 2003 179 182
34. C.F. Netto, and F.S. Guimarães Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray Neuropsychopharmacology 29 1 2004 101 107
35. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 4th ed. 1998 Academic Press San Diego 130 pp
36. J.K. Pereira, R.J. Vieira, C.T. Konishi, R.A. Ribeiro, and R. Frussa-Filho The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation Life Sci 65 10 1999 101 107
37. R.J. Rodgers, and J.K. Shepherd Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice Psychopharmacology 113 2 1993 237 242
38. A.S. Russo, F.S. Guimarães, J.C. Aguiar, and F.G. Graeff Anxiolytic effect of midazolam microinjected into the dorsal periaqueductal grey area of rats Braz J Med Biol Res 24 1991 607 609
39. L.C. Schenberg, A.S. Bittencourt, E.C.M. Sudré, and L.C. Vargas Modeling panic attacks Neurosci Biobehav Rev 25 2001 647 659
40. M.C. Silveira, G. Sandner, and F.G. Graeff Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze Behav Brain Res 56 1993 115 118
41. E.J. Tehovnik, and M.A. Sommer Effective spread and timecourse of neural inactivation caused by lidocaine injection in monkey cerebral cortex J Neurosci Methods 74 1 1997 17 26
42. K.V. Teixeira, and A.P. Carobrez Effects of glycine or (+/-)-3-amino-1-hydroxy-2-pyrrolidone microinjections along the rostrocaudal axis of the dorsal periaqueductal gray matter on rats' performance in the elevated plus-maze task Behav Neurosci 113 1 1999 196 203
43. D. Treit, J. Menard, and C. Royan Anxiogenic stimuli in the elevated plus-maze Pharmacol Biochem Behav 44 1993 463 469